Sandy Spring Bank’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $19.8K | Buy |
582
+20
| +4% | +$681 | ﹤0.01% | 737 |
|
|
2024
Q4 | $22.1K | Sell |
562
-930
| -62% | -$36.6K | ﹤0.01% | 732 |
|
|
2024
Q3 | $70.1K | Hold |
1,492
| – | – | ﹤0.01% | 525 |
|
|
2024
Q2 | $80.6K | Hold |
1,492
| – | – | ﹤0.01% | 493 |
|
|
2024
Q1 | $102K | Buy |
1,492
+110
| +8% | +$7.5K | ﹤0.01% | 463 |
|
|
2023
Q4 | $86.5K | Hold |
1,382
| – | – | ﹤0.01% | 467 |
|
|
2023
Q3 | $62.7K | Hold |
1,382
| – | – | ﹤0.01% | 505 |
|
|
2023
Q2 | $77.6K | Hold |
1,382
| – | – | ﹤0.01% | 463 |
|
|
2023
Q1 | $62.5K | Hold |
1,382
| – | – | ﹤0.01% | 497 |
|
|
2022
Q4 | $56.2K | Sell |
1,382
-42
| -3% | -$1.71K | ﹤0.01% | 511 |
|
|
2022
Q3 | $93K | Sell |
1,424
-15
| -1% | -$980 | 0.01% | 422 |
|
|
2022
Q2 | $87K | Hold |
1,439
| – | – | 0.01% | 433 |
|
|
2022
Q1 | $90K | Hold |
1,439
| – | – | ﹤0.01% | 432 |
|
|
2021
Q4 | $109K | Hold |
1,439
| – | – | 0.01% | 427 |
|
|
2021
Q3 | $161K | Hold |
1,439
| – | – | 0.01% | 354 |
|
|
2021
Q2 | $233K | Buy |
1,439
+300
| +26% | +$48.6K | 0.01% | 322 |
|
|
2021
Q1 | $139K | Buy |
1,139
+106
| +10% | +$12.9K | 0.01% | 355 |
|
|
2020
Q4 | $158K | Hold |
1,033
| – | – | 0.01% | 335 |
|
|
2020
Q3 | $86K | Sell |
1,033
-20
| -2% | -$1.67K | 0.01% | 384 |
|
|
2020
Q2 | $77K | Buy |
1,053
+121
| +13% | +$8.85K | 0.01% | 390 |
|
|
2020
Q1 | $40K | Buy |
+932
| New | +$40K | ﹤0.01% | 472 |
|